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Search for a novel anti-inﬂammatory agent from a herbal source, such as Eupatorium adenophorum Spreng., a plant from the
Eastern Himalayas, is of prime interest in the present investigation. Inﬂammation causes tissue destruction and development of
diseases such as asthma, rheumatoid arthritis, and so forth. The ethanolic leaf extract of E. adenophorum (EEA) was administered
intravenously and in other cases topically at the site of delayed type hypersensitivity (DTH) reaction in mouse foot paw induced
with dinitroﬂuorobenzene. EEA can eﬀectively inhibit DTH reaction and bring back normalcy to the paw much earlier than the
controls.EﬃcacyofEEAonregulatorymechanismsforinﬂammationhasalsobeenconsidered.IntravenousadministrationofEEA
increased the number of CD4+ T cells in spleen and tumor necrosis factor (TNF)-α in serum of DTH mice. Initially it was diﬃcult
to reconcile with the anti-inﬂammatory role of EEA and simultaneous induction of TNF-α, an established pro-inﬂammatory
cytokine. EEA induces higher expression of TNF-α gene and amount of the cytokine in serum. We discussed the other role
of TNF-α, its involvement in repairing tissue damage incurred in course of inﬂammatory reaction. EEA also induces TGF-β
encoding a cytokine involved in tissue repair mechanism. EEA inhibits expression of another pro-inﬂammatory cytokine gene IL-
1β and downregulates cycloxygenase 2 (COX2) gene responsible for metabolism of inﬂammatory mediators like prostaglandins.
Furthermore, anti-inﬂammatory role of EEA is also revealed through its inhibition of hydroxyl radical generation. Notably EEA
does not necessarily aﬀect the expression of other inﬂammation-related genes such as IL-6, IL-10 and IKK.T h ep r e s e n ts t u d y
reports and analyzes for the ﬁrst time the anti-inﬂammatory property of the leaf extract of E. adenophorum.
1.Introduction
Inﬂammation is the body’s way of dealing with infections,
maintaining a subtle balance between the beneﬁcial eﬀects of
inﬂammation cascades to restrict the infection and potential
for long-term tissue destruction [1–3]. If not controlled,
inﬂammation can lead to development of diseases such
as chronic asthma, rheumatoid arthritis, multiple sclerosis,
inﬂammatory bowel disease, and so forth, [4–9]. Till date a
very few anti-inﬂammatory drugs from herbal origin have
been found, and a number of plants from ethno-medicinal
databasesareunderlaboratoryinvestigationacrosstheworld
[10].
The plant Eupatorium adenophorum Spreng. (Figure 1)
belongs to the family Asteraceae (Compositae) [11]. A num-
ber of plants of this family are commonly used in folklore
medicineindiﬀerentpartsoftheworld[12–19].InKurseong
and Darjeeling hill region of the Eastern Himalayas, local
people use leaves of E. adenophorum Spreng., growing at an
altitude of 800–2050m, for remedial purposes against oral
andskinsores.Theseobservationssuggestedaprobableanti-
inﬂammatory and immunomodulatory activity of the plant’s
leaf extract. Earlier Mandal et al. [20] reported analgesic
property of methanolic extract of the leaves. The present
investigation intends to explore the anti-inﬂammatory
property of ethanolic leaf extract of E. adenophorum Spreng.
(EEA) in delayed type hypersensitivity (DTH) induced by
2,4-dinitroﬂuorobenzene (DNFB) in mouse model.
DTH reaction is initiated by pre-sensitized CD4+ TDTH
cells [21] and then other inﬂammatory cells and cytokines2 Evidence-Based Complementary and Alternative Medicine
are involved at the site of reaction. The number of CD4+
T cells in course of DTH reaction and treatment with EEA
has been enumerated to understand the eﬀect of EEA on
these cells. TNF-α is the most important cytokine that plays
a major role in all the inﬂammation reactions. Serum TNF-α
of DTH mice has also been investigated in the present study
in course of inﬂammation.
Many reports reveal that reactive oxygen species (ROS)
play an important role in developing various pathophys-
iological conditions including inﬂammation [22–25]a n d
potent anti-inﬂammatory agents can scavenge the free rad-
icals to quench the biochemical ﬁre [26–28]. The hydroxyl
radical (OH−) especially plays a crucial role in developing
inﬂammation.Scavengingofhydroxylradical(OH−)byEEA
has been studied.
Besides TNF-α, many other cytokines play a key role in
orchestrating immune responses in inﬂammation [29–36].
Here, expression of some cytokine genes such as TNF-α,I L -
1β,I L - 6 ,I L - 1 0a n dT G F - β in splenic T cells of DTH mice
has been studied at transcription level with and without
intravenous (i.v.) application of the plant extract. Expression
of inhibitory kappa kinase (IKK) gene has also been judged.
The enzyme degrades IκB subunit to release active NF-
κB[ 37, 38], that is, involved in activating inﬂammatory
responses as shown by Tak and Firestein [39] and Yamamoto
and Gaynor [40].
The expression of COX1 and COX2 genes encoding two
isozymes of cycloxygenase has been taken into account here.
Cycloxygenaseisknowntoplayasigniﬁcantroleininduction
of inﬂammation by producing inﬂammatory mediators like
prostaglandins and leukotrienes from arachidonic acid [41–
47].
2. Methods
2.1. Animal. Inbred adult Swiss Albino mice of both sexes,
12–16 weeks old have been used. They are maintained
in our animal house with food and water ad libitum.
Animals of approximately equal age and weight were used
for experimental and control groups in the experiment.
The experimental protocols used in the study have been
approved by the Animal Ethical Committee (Regn No.
840/ac/04/CPCSEA).
2.2. Extract Preparation. Extract was prepared from fresh
leaves of the plant E. adenophorum using the protocol
outlined earlier [48–51]. Leaves were collected from their
natural habitat at about 1400m high slope of the Eastern
Himalayas, mainly around Kurseong hill. The scientiﬁc
identiﬁcationoftheplanthasbeencheckedbyProfessorA.P.
Das,PlantTaxonomyLab.,DepartmentofBotany,University
of North Bengal. The leaves were cleaned thoroughly with
water and allowed to air dry. In total, 10g of leaves were
crushed to a paste with a mortar and pestle. An amount
of 10mL of absolute alcohol (ethanol) was added to the
paste and kept in a refrigerator overnight for extraction. The
alcoholic extract was then ﬁltered ﬁrst through Whatmann
ﬁlter paper and the ﬁltrate was reﬁltered again through
cellulose acetate ﬁlter paper (0.2μm porosity, Sartorius) for
Figure 1: Photograph of E. adenophorum Spreng. in its natural
habitat.
sterilizationandﬁnallystoredinairtightsterilizedvialat4◦C.
T h ee x t r a c tw a su s e da ss u c hf o rd i ﬀerent experiments.
2.3. Experimental and Control Sets and Statistical Analysis. In
all the experiments, the eﬀect of EEA was compared with
two sets of control, one with equivalent amount of ethanol
present in EEA and the other without any treatment. Each
experiment was done on the basis of triplicate readings and
such an experiment was repeated thrice or more. Results
are expressed as Mean ± SD of at least nine observations.
Statistical signiﬁcance was analyzed using one-way ANOVA
software package.
2.4. Induction of Delayed Type Hypersensitivity Reaction with
2,4-DNFB and Application of EEA. Delayed type hypersen-
sitive (DTH) reaction was induced in mouse foot paw by
subcutaneous application of 2,4-DNFB [48, 52]. Primary
sensitization was carried out by applying 0.0001% DNFB
subcutaneously in the right foot pad. After 8 days, mice were
resensitized with 0.000001% DNFB on the left foot pad. Two
diﬀerent volumes of percentage solutions of DNFB, 25 or
50μL for both sensitization and resensitization, were used
in separate experimental setups. The day of resensitization
was considered as “0” day for enumeration of DTH reaction.
The size of the left paw before resensitization was considered
as normal size for the paw. The degree of inﬂammatory
swelling set in the resensitized left paw was measured by
a slide caliper. The eﬀect of EEA on DTH reaction set in
by two diﬀerent doses of DNFB was judged after topical or
i.v. application of the extract. For topical application, 5μL
of EEA was applied on the resensitized paw per day from
ﬁrst day of resensitization. For i.v. administration, 25μLo f
EEA was used 1h prior to resensitization. The percentage
of inhibition of inﬂammation by EEA in reference to theEvidence-Based Complementary and Alternative Medicine 3
ethanol control has been calculated by using the following
formula:
Inhibitionof DTH (%)
=
Untreated DTH pawsize −Experimentalpaw size
Untreated DTH pawsize
×100.
(1)
2.5. Isolation of CD4+ T Cells Through Magnetic Assorted
Cell Sorter (MACS). The splenic lymphocytes were obtained
from untreated DTH mice and mice intravenously injected
with EEA and ethanol after 24, 48 and 72 h of resensitization
following the protocol of Chakravarty and Maitra [53]. Ery-
throcytesinthespleencellsuspensionwerelysedbyexposure
to Tris-buﬀered ammonium chloride (0.83%, pH 7.2). For
depletion of adherent cells, the suspension was incubated in
a plastic petri dish at 37◦C in humidiﬁed atmosphere for
30min. Non-adherent lymphocyte population was collected
and centrifuged and ﬁnally resuspended at a concentration
of 107 cells in 80μL. To the aliquot of 80μL cell suspension,
20μLo fC D 4 + (L3TH) microbeads (130-049-201, Miltenyi
Biotech,Germany)[54–56]withamagneticprobewasadded
in the test tube. The tubes were refrigerated at 4–6◦Cf o r
attachment of the bead to the CD4+ cells for 15 min. The
mixture of cells and magnetic beads is then poured into the
magnetic separation (MS) column ﬁtted in the slot of the
magnet of MACS. The unlabeled cells passed through the
c o l u m na n dw e r ec o l l e c t e di nat u b e .T h eM Sc o l u m nw a s
removed from the separator and placed in a fresh collection
tube. Of PBS, 1 ml was pipetted onto the MS column and
labeled CD4+ cells were ﬂushed out from the column by
ﬁrmly pushing the designated plunger into the column.
The magnetic labeled CD4+ cells were then counted in a
hemocytometer.
2.6. Estimation of Serum TNF-α. The quantitation of serum
TNF-αofDTHbearingmicetreated(i.v.)withEEAandcon-
trol mice was performed by solid phase sandwich enzyme-
linked immunosorbent assay (ELISA) kit (Pharmingen,
USA) following the protocol outlined by Paul et al. [57–59].
2.7. Hydroxyl Radical Scavenging Assay. The hydroxyl radi-
cal (OH−)w a sg e n e r a t e df r o mF e 2+-ascorbate-EDTA-H2O2
system (Fentons’ reaction). Assay reaction mixture was
prepared by mixing a 20mM phosphate buﬀer, 2mM FeCl3,
1mM EDTA, 2.8mM 2-deoxy d-ribose, 1mM H2O2 and
1mMl-ascorbic acid. OH− reacts with the deoxy d-ribose
and a series of reaction follows to form malonaldehyde
(MDA) [60]. An aliquot of 1 ml of the reaction mixture
was added in each tube of experimental, alcohol control
and normal control sets and incubated at 37◦Cf o r1 h .
Two diﬀerent doses of EEA, 10 and 25μL, were tested
for scavenging hydroxyl radical. In alcohol and normal
control, same volume of ethanol and water was added
respectively.Afterincubation,2mLofTBA–TCAreagentwas
added in each tube and boiled for 15min for generation
of MDA. MDA generated was measured at 552nm in a
spectrophotometer. The eﬀect of both EEA and alcohol
on generation of hydroxyl radical has been expressed as
percentage of inhibition in MDA generation over normal
control sets. The formula used is given below:
Percentage ofinhibition =

100 −
MDAgenerated inexperimental/alcoholcontroltubes
MDA generatedinnormalcontroltubes

%. (2)
2.8. Gene Expression Analysis. Expression of the genes of
interest in this study has been carried out using single-cell
RNA phenotyping procedure as outlined by Rappolee et al.
[47, 61, 62].
2.9. RNA Isolation. RNA was isolated from splenic T cells
of nine mice in each group using RNeasy Mini kit (74104,
Qiagen, Valencia, CA, USA), as per manufacturer’s protocol.
Brieﬂy, 6 × 106 T cells were homogenized with a 300μLR L T
buﬀer and passing them through a 2mL syringe ﬁtted with a
27-gauge needle. Of 70% ethanol, 300μL was added to the
homogenate and collected in a spin column ﬁtted upon a
collection tube. The spin columns and collection tubes were
supplied by the manufacturer. After a brief centrifugation for
15s at 10000rpm, the ﬂuid was passed into the collection
tube that was then decanted and reattached to the spin
column. With addition of 500μLo fb u ﬀer RW1 into the spin
columncentrifugationwasmadeagainfor15sat10000rpm.
Following decantation of collection tube, 500μLo fb u ﬀer
RPE was added to the spin column and centrifuged similarly,
and the step was repeated one more time. Finally, the spin
column was ﬁtted upon a fresh collection tube and washed
twice with 15μLo fD E P C - t r e a t e dw a t e rt oc o m eu pw i t ha
total of 30μL volume containing the RNA sample.
The concentration of RNA was measured spectrophoto-
metrically at 400× dilution with Shimadzu UV-160, Japan.
The extracted RNA was used for cDNA synthesis.
2.10. cDNA Synthesis. The isolated RNA was used for First
strand cDNA synthesis utilizing the RevertAid First strand
cDNA synthesis kit # K1621 from Fermentas and the
manufacturer’s protocol was followed. For synthesis of ﬁrst
strand cDNA, the primer used for PCR ampliﬁcation was
oligo(dT13) synthesized by GMBH. cDNA constructed was
stored at −20◦C for further use.
2.11. Primer Utilized and Ampliﬁcation Schedule. Primers
were designed from various geneBank accession retrieved
from PUBMED Data Bank as listed in Table 1, using the
primer program available on the internet. The designed4 Evidence-Based Complementary and Alternative Medicine
Table 1: Primers.
Primers Accession number Sense (5 –3 ) Antisense (3 –5 ) Tm (◦C)
IKK NM 010546 CCAGACTCCAAGGTGGTGTT TGCAGATCACAGGCAGAAAC 60.0
TNF-α NM 013693 TGGCACAGCCAAG GGGACCCCTGCTC 52.36
TGF-β NM 011577 TTGCTTCAGCTCCACAGAGA TGGTTGTAGAGGGCAAGGAC 59.99
IL-1β NM 008361 GTGGCAGCTACCTGTGTCTT GGAGCCTGTAGTGCAGTTGT 57.96
IL-6 NM 031168 GGGAAATCGTGGA AGGTTTGCCGAGT 43.9
IL-10 NM 010548 CCAAGCCTTATCGGAAATGA TTTTCACAGGGGAGAAATCG 60.035
COX1 BC023322 AGAAACTGGTCTGCCTCA AACCCACATCAAGGACTG 54.02
COX2 NM 011198 AGCACCATTCTCCTTGAA GTAGGCTGTGGATCTTGC 54.0
PKC-θ NM 008859 AAGTGAGAAACCCCGGCTAT AGGCAAATCCCTTCCAGTCT 60.01
Perforin NM 011073 ACCCTGAATGGGCTCACA GCAGCAGTCCTGGTTGGT 57.0
primers were synthesized by GMBH, Germany. Details of the
primers are given in Table 1.
PCR was performed using a thermocycler (PeqLab, Ger-
many) for 35 cycles in a 30μL reaction mixture containing
Taq DNA polymerase buﬀer, all four dNTPs, oligonucleotide
primers, Taq DNA polymerase and cDNA products. After
ampliﬁcation, PCR products were analyzed on a 0.8% (w/v)
agarose gel. The band density was quantiﬁed on the basis of
the known concentration of lambda DNA (30ng) through
ImageAide, Spectronics Corporation, NY.
3. Results
3.1. Eﬀect of EEA on Delayed Type Hypersensitive Reaction
3.1.1. With Topical Application. Figure 2 represents the data
of delayed type hypersensitivity reaction induced with
25μL DNFB and treatment with ethanolic leaf extract
of E. adenophorum (EEA) (experimental) and ethanol in
control. Swelling of resensitized paw in both control and
experimental mice was maximum on third day; with topical
application of EEA, the maximum swelling was in the range
of 0.4733 ± 0.0227cm, and in ethanol-treated control mice
the maximum value was 0.5667 ± 0.173cm (Figure 2). The
paw size in EEA-treated mice gets back to normal range by
the ninth day of resensitization. Inhibition with EEA is a
continuousprocessthroughouttheexperiment.Figure 2also
represents the percentages of inhibition on diﬀerent days.
A higher dose (50μL) of DNFB causes the swelling to be
moreandthepeakonthesecondday;however,recoverywith
EEA treatment is on the ninth day (Figure 3). In fact EEA
inhibitedtheswellingby60%ontheninthday.Figure 4isthe
photographic representation of DTH reaction induced with
50μL DNFB and inhibition with EEA treatment.
3.1.2. With i.v. Application. When EEA was administered
intravenously in DTH bearing mice, inﬂammatory swelling
of the resensitized paw persisted longer than in cases of
topical application of EEA. The dose of 25μLD N F Bc o u l d
inducemaximumswellingof0.963 ±0.012cmonthesecond
day in untreated mice. Intravenous application of EEA
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Figure 2: Inhibitory eﬀect of topical application of EEA on delayed
type hypersensitive (DTH) reaction induced with 25μL 2,4-DNFB
(signiﬁcance at ∗P<. 01).
caused the DTH reaction to slow down. In alcohol group
the swelling was maximum, 0.7367 ± 0.0045cm, on ﬁfth
day (also on sixth). EEA treatment restricted the swelling to
0.5123 ± 0.0112cm on ﬁfth day and brought back normalcy
(0.2967 ± 0.0103 cm) by 11th day; the inhibition over the
ethanol control was found to be 45.39% (Figure 5).
T h ed e g r e eo fs w e l l i n gw a sm o r ea tD T Hs i t ew i t hh i g h e r
dose(50μL)ofDNFB(Figure 6.)inhibitedthereactionmore
eﬀectivelythanalcoholalone(control)andallowedregaining
normalcy by 13 days (Figure 6).
3.2. Estimation of the Number of CD4+ T Cells in DTH Mice.
CD4+ T cells from splenic lymphocyte population were iso-
lated by labeling with microbeads containing a paramagnetic
probe and passing through MACS. The number of CD4+ T
lymphocytes in the spleen of DTH mice treated with EEAEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Indurations of DTH swelling, induced with 50μL
DNFB, and inhibition after topical application of EEA and alcohol
(signiﬁcance at ∗P<. 01).
EEA treated 0day
2ndday
4thday
7thday
9thday
Ethanol treated
Figure 4: Photographs showing eﬀect of topical application of EEA
and alcohol on resensitized paw of DTH mice, induced by 50μL
DNFB, during 9-day period of the study.
wassigniﬁcantlymorethanthecontrols,abouttwoandahalf
times at 24 and 48h and two times at 72h (Figure 7).A slight
increase in the cell number in the alcohol control group was
noted (Figure 7).
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Figure 5: Changes in paw size of DTH mice, induced with 25μL
DNFB, and after i.v. application of EEA and alcohol (signiﬁcance of
inhibition by EEA at ∗P<. 01 and ∗∗P<. 05).
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Figure 6: Changes in paw size of DTH mice, induced with 50μL
DNFB, and after i.v. application of EEA and alcohol (signiﬁcance of
inhibition by EEA at ∗P<. 01).
3.3. Serum TNF-α of DTH-Bearing Mice and Upon EEA
Treatment. Serum TNF-α in three groups of mice bearing
DTH reaction—untreated, alcohol and EEA treated (i.v.)—
was measured by a solid phase sandwich enzyme-linked
immunosorbent assay (ELISA).
There was no appreciable diﬀerence in the level of serum
TNF-α in the three groups of mice at 24h (Figure 8). The
TNF-α level in DTH mice treated with EEA (i.v.) was more
than that in other groups by 48h (93.23pgmL−1) and the
level was maintained upto 72h (Figure 8).
3.4. Generation of Hydroxyl Radical and Eﬀect of EEA. The
hydroxyl radical (OH
•) is potentially harmful for the cellular6 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Eﬀect of intravenously administered EEA and alcohol on
count of CD4+ T cells from spleen of mice after 24, 48 and 72h of
induction of DTH with 25μL DNFB (signiﬁcance of results with
EEA over control at ∗P<. 01).
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Figure 8: Level of serum TNF-α from DTH mice (induced with
25μLD N F B )a tt h r e ed i ﬀerent hours in presence and absence of
EEA (signiﬁcance compared to controls at ∗P<. 01).
macromolecules and is implicated in pathophysiology of
inﬂammation. EEA inhibits hydroxyl radical generation up
to 57.98% at a dose of 25μL .T h es a m ed o s eo fe t h a n o l
(control)showed23.62%inhibition.Atalowerdoseof10μL,
the degree of inhibition was about 49.25% in experimental
ones and 14.88% in case of alcohol control (Figure 9).
3.5. Expression of Certain Genes in Splenic T Cells of DTH
Mice with and without EEA Treatment. The T cells actively
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Figure 9: The eﬀect of two diﬀerent doses of EEA on inhibition of
generation of hydroxyl radical (OH
•).
participate in the progression of DTH reaction. Up- or
downregulation of certain genes in the cells must be related
to the production of pro- and anti-inﬂammatory cytokines,
transcription factors and mediators. The level of expression
of some of these genes at transcription level in splenic T cells
of DTH mice untreated and treated with EEA was judged, by
quantitating the cDNA PCR product ampliﬁed with speciﬁc
primers. The quantitation was done against 30 ng of lambda
DNA as a standard using ImageAide, Spectronics Corpora-
tion, NY. The data are presented in Figures 10 and 11.
EEA caused an increment in the expression of TNF-α,
a pro-inﬂammatory cytokine (Figures 10 and 11). At the
same time, EEA inhibited expression of pro-inﬂammatory
cytokine IL-1β and showed no eﬀect on IL-6, another pro-
inﬂammatory cytokine.
EEA did not inﬂuence the expression of IL-10, an anti-
inﬂammatory cytokine beyond alcohol control. The expres-
sion of TGF-β encoding a cytokine involved in regeneration
was induced by EEA beyond the level in the controls.
EEA apparently did not inﬂuence expression of IKK and
COX1 genes but downregulated the expression of COX2
gene.
4. Discussion
The ethanolic leaf extract of E. adenophorum Spreng. (EEA)
could eﬀectively suppress the inﬂammatory reaction set in
foot paw by injecting two diﬀerent doses of 2,4-DNFB
(Figure 4). The topical application of EEA was more eﬀective
in inhibition of the swelling of foot paw and gaining nor-
malcy faster than its i.v. application (Figures 2, 3, 5,a n d6).
EEA treatment caused signiﬁcant increase in the number
of the CD4+ T cell population in DTH mice (Figure 7).
These cells are known to play a central role in inﬂammatory
reactions by secreting all diﬀerent kinds of cytokines that
regulate participation of other kinds of cells [21, 63, 64].Evidence-Based Complementary and Alternative Medicine 7
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Figure 10: Expression of certain inﬂammation-related genes in
T cells obtained from DTH mice, and with and without EEA
treatment, containing nine mice in each group. Agarose gel
electrophoresis of cDNA PCR products ampliﬁed with diﬀerent
gene-speciﬁc primers.
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DNA bands presented in Figure 10 showing expression of the
inﬂammation-related genes in T cells of DTH mice with and
without EEA treatment, containing nine mice in each group. The
DNA bands were quantiﬁed against 30 ng of lambda DNA through
ImageAide, Spectronics Corporation, NY.
TNF-α is a major cytokine involved in DTH reaction.
EEA induced higher level of serum TNF-α, surpassing the
level in mice undergoing DTH reaction or in mice treated
with alcohol (Figure 8). It is worthwhile to note EEA capable
DNFB on 0day
(sensitization)
DNFB on 8thday
(resensitization)
25μL EEA i.v. 1hr prior
to resensitization
DTH reaction in left paw
inhibited by EEA
Eﬀect of EEA on CD4+ Tc e l l s
expression of genes (related to DTH)
Quenching of OH•
↓IL-1β ↓COX-2 ↑TNF-α ↑TGF-β
Inhibition of
inﬂammation
Repairing process
aftermath inﬂammation
Back to normal
Figure 12: Eﬀect of EEA on inhibition of DTH reaction and repair
mechanism presented schematically.
of inhibiting DTH reaction is inducing a pro-inﬂammatory
cytokine like TNF-α. Banno et al. [65] showed that TNF-α
promotes tissue repair of damage skin by inducing basement
membrane components and collagen degrading proteases to
participate actively in reconstruction of extracellular matrix.
Kuwano and his coworkers [66] found that TNF-α can
also induce growth-promoting event like angiogenesis by
increasing mRNA level of IL-8, vascular endothelial growth
factor and ﬁbroblast growth factors in endothelial cells. We
think of similar participation of TNF-α in tissue repair and
regeneration to bring back normalcy aftermath of DTH
reaction.Thus,TNF-αplaysadoubleroleinDTHreaction—
pro-inﬂammatory cum restoring agent.
The ability of EEA for induction of TNF-α gene was
studied next. Indeed, it induced higher level of expression of
the gene (Figures 10 and 11). EEA does not necessarily aﬀect
the expression of gene for other pro-inﬂammatory cytokines
such as IL-1β and IL-6 in a similar fashion. EEA inhibited
IL-1β expression and did not inﬂuence the expression of
IL-6 gene (Figures 10 and 11). It seems that IL-1β without
any known function in repair mechanism manifests more
inhibitoryeﬀectofEEAoninﬂammation.Stimmederandhis
co-workers [67] observed that lornoxicam and other non-
steroidal anti-inﬂammatory drugs inhibit IL-1β expression
as well as inﬂammation. Kohli et al. [68] reported that
curcumin, the active component in the rhizome of Curcuma
longa Linn., demonstrates its anti-inﬂammatory activity by
inhibiting production of IL-1β in lung inﬂammatory cells.
An anti-inﬂammatory agent does not necessarily always
regulate all the anti-inﬂammatory cytokine genes as we ﬁnd
that in the present study EEA does not inﬂuence the anti-
inﬂammatory cytokine gene IL-10 (Figures 10 and 11).8 Evidence-Based Complementary and Alternative Medicine
EEA upregulates expression of TGF-β (Figures 10 and
11). TGF-β performs as a growth factor in all diﬀerent
kinds of events of collagen production and extracellular
matrix reorganization as shown by Barcellos–Hoﬀ [69]. This
cytokine might function here to restore normalcy along with
TNF-α in repair mode as discussed earlier. Simultaneous
upregulation of these two genes have also been observed
by Chao et al. [70] in microglial cell culture. Sullivan et
al. [71] also reported similar trend in expression of these
two cytokines in interstitial pulmonary ﬁbrosis-aﬀected lung
ﬁbroblasts.
Tak and Firestein [39] and Yamamoto and Gaynor [40]
elucidated involvement of NF-κB pathway for induction of
inﬂammation. Activation of NF-κB is mediated by the action
of Inhibitory kappa kinase (IKK) degrading inhibitory IκB
subunit. Thus, measuring the expression of IKK,o n ec a n
derive the involvement of NF-κB pathway in a reaction. EEA
could not induce the expression of IKK gene beyond the
controls (Figures 10 and 11) indicating non-involvement of
NF-κB activation pathway for DTH reaction induced with
DNFB.
COX1 and COX2 gene products are two isoforms of the
cycloxygenaseenzymethatmetabolizesarachidonicacidinto
the inﬂammatory mediators like prostaglandins and leuko-
trienes [41–47]. Notably EEA only inﬂuences expression
of COX2 gene by way of inhibition (Figures 10 and 11).
This may be another way of execution of anti-inﬂammatory
activity by EEA. Salvioli et al. [72] reviewed curcumin,
a potent anti-inﬂammatory agent, also inhibits COX2 in
abetting inﬂammation.
Itisknownthatreactiveoxygenspeciesplayanimportant
role in development of inﬂammation [22–25]. In the present
study, the ability of EEA in quenching the generation of
hydroxyl radical has been tested and found to be eﬀective
(Figure 9).
In summary, ethanolic leaf extract of E. adenophorum
(EEA) exerts anti-inﬂammatory activity (Figure 12), likely
through inhibition of IL-1β, COX2 genes and quenching
ROS like hydroxyl radical. Simultaneously EEA induces
production of TNF-α, a pro-inﬂammatory cytokine. This
paradox can only be resolved in the light of participation
of TNF-α in tissue repair in the aftermath of inﬂammation.
Interestingly, the expression of TGF-β gene encoding the
cytokine responsible for growth and repair mechanism is
also inducible by EEA. E. adenophorum as a source of anti-
inﬂammatory substance seems worthy to report. The active
compound from the extract is yet to be identiﬁed. Isolation
ofthatcompoundwillallowunderstandingmolecularmech-
anism of the activity of the substance. So far, Zhang et al.
[73] reported presence of a few ﬂavonones and sesquiterpene
lactones in E. adenophorum.
The present investigation also intends that any herbal
agent having anti-inﬂammatory property might be screened
faster by estimating its ability to induce or inhibit the genes
encoding substances participating in inﬂammation.
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